Palantir's Q1 earnings failed to meet guidance expectations, driving selloff concerns. Find out if PLTR has more to rise or ...

US stocks dropped as the Nasdaq 100 and Palantir tumbled, with traders eyeing Fed policy signals and unresolved global trade ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Palantir reported a 71% increase in U.S. commercial revenue and a 45% gain in U.S. government revenue in the period, showing ...

ARM Holdings executives reassured investors that the company's business model provides protection from direct tariff impacts ...

The rise of artificial intelligence (AI) is expected to add $15.7 trillion to the worldwide economy by 2030. AI colossus ...

Palantir Technologies ( PLTR 1.44%) shares have advanced 550% since January 2024. For context, it was the best performing ...

Despite impressive revenue and operating income growth, Palantir shares dropped 12%. Read what warrants caution about PLTR ...

Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Shares have advanced in Asia after the U.S. and China said they are planning trade talks in Switzerland later this week ...

After the closing bell on May 5, Palantir (PLTR) reported its highly anticipated Q1 2025 results, which beat analysts’ ...